The World Has More GLP-1s but Who Can Afford Them? Part 2 - A GLP-1 Guide to Metabolic Health: The Plus SideZ Podcast | Lyssna här

Linktree - our favorite links (https://linktr.ee/dinosaurmonkeyfarts)

NEW: Need GLP-1 Care? Join me at Belle! Use Podcast at checkout to save!
https://link.joinbelle.com/podcast

NEW: Cozy Butter GLP-1 Community! Join Free (https://cozybutter.com/)
https://cozybutter.com/

A GLP-1 community where support isn’t at the mercy of the algorithm.

Live GLP-1 support groups
Live support groups and social events
Health coaching and expert Q&As
Cooking, movement, and stress-management classes
GLP-1 tools and guidance (water, protein, side effect management, etc.)
A dedicated community beyond the algorithm

Book at 1 on 1 with Kim (https://calendly.com/theplussidez/kim...)

The World Has More GLP-1s but Who Can Afford Them? Part 2

This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication.

Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world.

In Part 2, we discuss:

• Managing daily life and side effects on GLP-1 medication
• Why weight loss slows and plateaus happen
• How the body’s set point may affect weight
• What GLP-1 maintenance really means
• Balancing continued weight loss with stabilization
• Adjusting treatment for long-term care
• What Ireland could learn from the U.S. rollout of GLP-1 medications

Dr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment.

CONNECT WITH OUR GUESTS

Dr. Michael “Mick” Crotty

My Best Weight
https://www.mybestweight.ie/

Instagram
https://www.instagram.com/mybestweight.ie/

LinkedIn
https://ie.linkedin.com/in/drmichaelcrotty

Belinda Hogan

Instagram
https://www.instagram.com/mid.life.insights/

The Dose with Paddy and Belinda
https://linktr.ee/TheDosePodcast

SOURCES

Oral Wegovy launches in Germany
https://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/

Hims & Hers expands its GLP-1 services into Australia
https://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/

600,000 people sign up for the Medicare obesity drug program
https://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/